A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer
Ontology highlight
ABSTRACT: Intervention name : OCV-C02
INN of the intervention : -
Dosage And administration of the intervention : Once-weekly subcutaneous injection (0.3, 1 3 and 6 mg/body)
Control intervention name : -
INN of the control intervention : -
Dosage And administration of the control intervention : -
Primary outcome(s): safety
Dose Limiting Toxicity (DLT)
Common Terminology Criteria for Adverse Events (CTCAE), ver. 4.0
Study Design: multicenter, open, non-comparative study
DISEASE(S): Advanced Or Relapsed Colorectal Cancer
PROVIDER: 2657927 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA